Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,889 | -23,945 | -89,122 | -68,275 | -43,446 |
| Depreciation Amortization | -1,612 | -608 | -76 | 297 | 446 |
| Other Working Capital | -720 | 311 | -445 | -3,166 | -5,531 |
| Other Operating Activity | 7,448 | 3,614 | 14,500 | 11,330 | 8,037 |
| Operating Cash Flow | $-41,773 | $-20,628 | $-75,143 | $-59,814 | $-40,494 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,820 | 13,088 | -107,170 | -135,757 | -135,473 |
| PPE Investments | -715 | -310 | -2,078 | -1,791 | -1,390 |
| Investing Cash Flow | $-6,535 | $12,778 | $-109,248 | $-137,548 | $-136,863 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 85,400 | N/A | 25,624 | 432 | 431 |
| Other Financing Activity | -226 | 0 | -399 | 0 | 0 |
| Financing Cash Flow | $85,174 | $N/A | $25,225 | $432 | $431 |
| Beginning Cash Position | 67,308 | 67,308 | 226,474 | 226,474 | 226,474 |
| End Cash Position | 104,174 | 59,458 | 67,308 | 29,544 | 49,548 |
| Net Cash Flow | $36,866 | $-7,850 | $-159,166 | $-196,930 | $-176,926 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,773 | -20,628 | -75,143 | -59,814 | -40,494 |
| Capital Expenditure | -715 | -310 | -2,078 | -1,791 | -1,390 |
| Free Cash Flow | -42,488 | -20,938 | -77,221 | -61,605 | -41,884 |